4//SEC Filing
CLARK IAN T 4
Accession 0001336504-25-000007
CIK 0001576280other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 9:36 PM ET
Size
20.5 KB
Accession
0001336504-25-000007
Insider Transaction Report
Form 4
CLARK IAN T
Director
Transactions
- Exercise/Conversion
Common Stock
2025-12-05$38.42/sh+9,105$349,814→ 18,956 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-12-05$38.01/sh+8,803$334,558→ 27,759 total(indirect: By Trust) - Exercise/Conversion
Common Stock
2025-12-05$31.84/sh+10,703$340,784→ 38,462 total(indirect: By Trust) - Sale
Common Stock
2025-12-05$106.67/sh−8,156$869,968→ 30,306 total(indirect: By Trust) - Sale
Common Stock
2025-12-05$107.27/sh−17,055$1,829,495→ 13,251 total(indirect: By Trust) - Sale
Common Stock
2025-12-05$108.05/sh−3,400$367,354→ 9,851 total(indirect: By Trust) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-05−9,105→ 0 totalExercise: $38.42Exp: 2032-06-15→ Common Stock (9,105 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-05−8,803→ 0 totalExercise: $38.01Exp: 2033-06-14→ Common Stock (8,803 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2025-12-05−10,703→ 0 totalExercise: $31.84Exp: 2034-06-12→ Common Stock (10,703 underlying)
Footnotes (6)
- [F1]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $105.88 to $106.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $106.88 to $107.87. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $107.885 to $108.480. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F4]The Stock Options vest in full on the one-year anniversary of the grant date, June 15, 2022 or the date of the next year annual stockholders meeting, whichever is earlier.
- [F5]The stock option vests in full on the one-year anniversary of the grant date, June 14, 2023 or the date of the next year annual stockholders meeting, whichever is earlier.
- [F6]The stock option vests in full on the one-year anniversary of the grant date, June 12, 2024 or the date of the next year annual stockholders meeting, whichever is earlier.
Documents
Issuer
Guardant Health, Inc.
CIK 0001576280
Entity typeother
Related Parties
1- filerCIK 0001336504
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 9:36 PM ET
- Size
- 20.5 KB